Related Experiment Videos

[Advances and perspectives in the prevention of venous thromboembolic disease]

M M Samama1

  • 1L'Hôtel-Dieu, Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|January 25, 2002
PubMed

Insights

Low molecular weight heparins (LMWH) significantly advance thrombo-embolic disease prevention. Current guidelines refine LMWH use, though optimal timing and duration post-surgery remain debated.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Orthopaedic Surgery

Context:

  • Thrombo-embolic (TE) disease is a leading cause of death, necessitating effective prevention strategies.
  • Low molecular weight heparins (LMWH) represent a significant advancement in TE disease prophylaxis.
  • Post-operative TE events stem from multifactorial origins, including patient-specific, environmental, and surgical factors.

Purpose:

  • To review the current evidence and recommendations for thrombo-embolic disease prevention using low molecular weight heparins (LMWH).
  • To highlight ongoing debates regarding LMWH administration timing, duration, and patient selection, particularly after major orthopaedic surgery.
  • To compare the efficacy of LMWH with other prophylactic agents like aspirin.

Summary:

  • Clinical studies and consensus meetings have refined recommendations for LMWH use in TE disease prevention, with evidence levels varying.
  • Major orthopaedic procedures like total hip replacement (THR) and total knee replacement (TKR) have extensive research, yet optimal prophylactic protocols are still discussed.
  • Key areas of debate include the timing of the first LMWH dose, the role of regional anesthesia, and the ideal duration of prophylaxis (10-14 days vs. 30 days).
  • Aspirin is generally considered less effective than heparins for TE prophylaxis.
  • Prophylaxis is indicated for specific groups in general medicine, such as post-myocardial infarction and immobilized patients with cerebrovascular accidents.
  • Prophylaxis is also justified in acute severe cardiac, pulmonary, or infectious diseases, though adherence to recommendations is inconsistent.

Impact:

  • Refined clinical practice guidelines for thrombo-embolic disease prevention.
  • Improved patient outcomes through optimized use of low molecular weight heparins.
  • Identification of areas requiring further research to resolve current clinical debates on LMWH therapy.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...